Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oxaliplatin (eloxatin) (3 trials)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Colorectal Neoplasms (Phase 3)
Gastrointestinal Neoplasms (Phase 3)
Genital Neoplasms, Female (Phase 3)
Prostatic Neoplasms (Phase 3)
Trials (3 total)
Trial APIs (1 total)